GMP細胞治療耗材全球市場規模、佔有率、趨勢及成長分析報告（2026-2034年）

全球GMP細胞治療耗材市場預計將從2025年的2,001萬美元成長至2034年的1.9466億美元，2026年至2034年的複合年成長率（CAGR）為28.76%。隨著製藥公司、生物技術公司和研究機構在嚴格控制的品質標準下擴大細胞療法的研發和生產，該市場正蓬勃發展。符合GMP標準的細胞治療耗材包括培養容器、培養袋、過濾器、導管、連接器、培養基容器以及細胞處理過程中所需的其他一次性產品。不斷擴展的細胞治療產品線推動了對可靠、無菌耗材的需求成長，這些耗材能夠支援穩定的生產流程。此外，對污染控制和製程可重複性的日益重視也促進了專用GMP級產品的應用。

一次性技術是成長要素的重要因素，因為與某些可重複使用系統相比，它們減少了清潔需求和交叉污染的風險。細胞療法生產商對支援封閉式或自動化處理流程的耗材的需求日益成長。為療法開發商提供細胞處理能力的合約開發和生產組織 (CDMO) 的擴張也推動了這一需求。隨著生產流程日益複雜，供應商正在開發更多用於細胞增殖、收集、過濾、儲存和冷凍保存的專用組件。

細胞療法的未來前景取決於其持續發展及其向規模化商業化生產的過渡。隨著自動化細胞處理系統的普及，對預先組裝的、特定應用耗材套裝的需求預計將會增加。製造商也可能專注於提高材料相容性、可追溯性、無菌性和供應可靠性。隨著研發公司將療法從研發和臨床試驗階段推進到商業化生產階段，對符合GMP規範的標準化耗材的需求將進一步成長。供應鏈韌性和法規遵循將繼續是影響該行業採購決策的關鍵因素。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業趨勢。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭動態以及主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長地區和區域趨勢，以更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察，以更好地支持您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球GMP細胞治療耗材市場：依產品類型分類

• 市場分析、洞察與預測
• 細胞培養基和添加劑
• 細胞分離純化耗材
• 冷凍保存耗材
• 細胞轉導耗材
• 其他耗材（實驗室設備、生物反應器等）

第5章：全球GMP細胞治療耗材市場：依細胞類型分類

• 市場分析、洞察與預測
• 幹細胞（胚胎幹細胞、誘導性多功能、成體幹細胞）
• T細胞
• 自然殺手（NK）細胞
• 其他細胞類型（樹突狀細胞、軟骨細胞等）

第6章 全球GMP細胞治療耗材市場：依應用領域分類

• 市場分析、洞察與預測
• 腫瘤學
• 再生醫學
• 神經病學
• 心血管系統
• 免疫學
• 其他用途

第7章 全球GMP細胞治療耗材市場：依最終用戶分類

• 市場分析、洞察與預測
• 生物製藥公司
• 契約製造組織（CMO）
• 學術和研究機構
• 醫院和診所
• 其他

第8章 全球GMP細胞治療耗材市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 中國
  • 日本
  • 韓國
  • 印度
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific Inc
  • Lonza Group
  • Merck KGaA
  • Corning Inc
  • Sartorius AG
  • Miltenyi Biotec
  • STEMCELL Technologies Inc
  • Takara Bio Inc
  • Bio-Techne Corporation
  • HiMedia Laboratories
  • Avantor Inc
  • Beckman Coulter Inc
  • Terumo BCT Inc
  • Roche Diagnostics
  • Fujifilm Irvine Scientific Inc
  • CellGenix GmbH

The global GMP cell therapy consumables market size is expected to reach USD 194.66 Million in 2034 from USD 20.01 Million in 2025, growing at a CAGR of 28.76% during 2026-2034.This market is expanding as pharmaceutical companies, biotechnology firms, and research institutions increase the development and manufacturing of cell-based therapies under controlled quality standards. GMP cell therapy consumables include culture vessels, bags, filters, tubing, connectors, media containers, and other single-use products required during cell processing. The growing pipeline of cell therapies is increasing demand for reliable and sterile consumables that can support consistent manufacturing. Greater emphasis on contamination control and process reproducibility is also encouraging adoption of specialized GMP-grade products.

Single-use technologies are an important growth driver because they can reduce cleaning requirements and cross-contamination risks compared with certain reusable systems. Cell therapy manufacturers increasingly require consumables that are compatible with closed or automated processing workflows. Demand is also supported by the expansion of contract development and manufacturing organizations, which provide cell-processing capabilities to therapy developers. Suppliers are developing more specialized components for cell expansion, harvesting, filtration, storage, and cryopreservation as manufacturing processes become increasingly sophisticated.

Future prospects are linked to the continued development of cell therapies and the transition toward scalable commercial manufacturing. Automated cell-processing systems are likely to increase demand for preassembled and application-specific consumable sets. Manufacturers may also focus on improved material compatibility, traceability, sterility assurance, and supply reliability. As developers move therapies from research and clinical stages toward commercial production, the requirement for standardized GMP-compatible consumables should increase. Supply-chain resilience and regulatory compliance will remain important factors influencing purchasing decisions across the sector.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product Type

• Cell Culture Media and Supplements
• Cell Separation and Purification Consumables
• Cryopreservation Consumables
• Cell Transduction Consumables
• Other Consumables (Labware, Bioreactors, etc.)

By Cell Type

• Stem Cells (Embryonic, Induced Pluripotent, Adult)
• T-Cells
• Natural Killer (NK) Cells
• Other Cell Types (Dendritic Cells, Chondrocytes, etc.)

By Application

• Oncology
• Regenerative Medicine
• Neurology
• Cardiovascular
• Immunology
• Other Applications

By End User

• Biopharmaceutical Companies
• Contract Manufacturing Organizations (CMOs)
• Academic and Research Institutions
• Hospitals and Clinics
• Others

COMPANIES PROFILED

• Thermo Fisher Scientific Inc., Lonza Group, Merck KGaA, Corning Inc., Sartorius AG, Miltenyi Biotec, STEMCELL Technologies Inc., Takara Bio Inc., Bio-Techne Corporation, HiMedia Laboratories, Avantor Inc., Beckman Coulter Inc., Terumo BCT Inc., Roche Diagnostics, Fujifilm Irvine Scientific Inc., CellGenix GmbH

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GMP CELL THERAPY CONSUMABLES MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Cell Culture Media and Supplements Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Cell Separation and Purification Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Cryopreservation Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Cell Transduction Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Consumables (Labware, Bioreactors, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GMP CELL THERAPY CONSUMABLES MARKET: BY CELL TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Cell Type
• 5.2. Stem Cells (Embryonic, Induced Pluripotent, Adult) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. T-Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Natural Killer (NK) Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Other Cell Types (Dendritic Cells, Chondrocytes, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GMP CELL THERAPY CONSUMABLES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Regenerative Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Cardiovascular Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Immunology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GMP CELL THERAPY CONSUMABLES MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Biopharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Contract Manufacturing Organizations (CMOs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Academic and Research Institutions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Hospitals and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL GMP CELL THERAPY CONSUMABLES MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product Type
  • 8.2.2 By Cell Type
  • 8.2.3 By Application
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product Type
  • 8.3.2 By Cell Type
  • 8.3.3 By Application
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Spain
  • 8.3.10 Russia
  • 8.3.11 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product Type
  • 8.4.2 By Cell Type
  • 8.4.3 By Application
  • 8.4.4 By End User
  • 8.4.5 China
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 India
  • 8.4.9 Australia
  • 8.4.10 South East Asia
  • 8.4.11 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product Type
  • 8.5.2 By Cell Type
  • 8.5.3 By Application
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product Type
  • 8.6.2 By Cell Type
  • 8.6.3 By Application
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL GMP CELL THERAPY CONSUMABLES INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher Scientific Inc
  • 10.2.2 Lonza Group
  • 10.2.3 Merck KGaA
  • 10.2.4 Corning Inc
  • 10.2.5 Sartorius AG
  • 10.2.6 Miltenyi Biotec
  • 10.2.7 STEMCELL Technologies Inc
  • 10.2.8 Takara Bio Inc
  • 10.2.9 Bio-Techne Corporation
  • 10.2.10 HiMedia Laboratories
  • 10.2.11 Avantor Inc
  • 10.2.12 Beckman Coulter Inc
  • 10.2.13 Terumo BCT Inc
  • 10.2.14 Roche Diagnostics
  • 10.2.15 Fujifilm Irvine Scientific Inc
  • 10.2.16 CellGenix GmbH